Literature DB >> 18179925

N-terminal B-type natriuretic peptide levels in pediatric patients with congestive heart failure undergoing cardiac surgery.

Rowan Walsh1, Clark Boyer, Jared LaCorte, Vincent Parnell, Cristina Sison, Devyani Chowdhury, Kaie Ojamaa.   

Abstract

OBJECTIVES: The objectives of this study were to measure circulating N-terminal B-type natriuretic peptide levels in pediatric patients undergoing surgical repair of congenital heart lesions with left ventricular volume overload and to determine whether presurgical and immediate postoperative N-terminal B-type natriuretic peptide levels could predict patient outcomes after surgical intervention.
METHODS: Thirty-eight children aged 1 to 36 months undergoing surgical repair of cardiac lesions with left ventricular volume overload were studied. Plasma N-terminal B-type natriuretic peptide levels were measured preoperatively and at 2, 12, 24, 48, and 72 hours after surgical intervention and were assessed for their predictive value of postoperative outcomes. Plasma N-terminal B-type natriuretic peptide levels were also measured in 34 similarly aged healthy children.
RESULTS: Patient preoperative N-terminal B-type natriuretic peptide levels were significantly higher than those of healthy control subjects (3085 +/- 4046 vs 105 +/- 78 pg/mL). Preoperative N-terminal B-type natriuretic peptide levels correlated with the complexity of surgical repair, as measured by cardiopulmonary bypass time (r = 0.529, P < .001), and with postoperative measures, including fractional inhaled oxygen requirements registered at 12 hours (r = 0.443, P = .005) and duration of mechanical ventilation (r = 0.445, P = .005). Plasma N-terminal B-type natriuretic peptide levels increased 5-fold within 12 hours after cardiopulmonary bypass (14,685 +/- 14,317 pg/mL). Multivariable regression analysis showed that the preoperative N-terminal B-type natriuretic peptide level was a significant predictor of duration of intensive care unit stay (P = .02) and that the peak postoperative N-terminal B-type natriuretic peptide level was a significant predictor of the intensity of overall medical management, as assessed by using the therapeutic intervention scoring system (P = .01).
CONCLUSION: Plasma N-terminal B-type natriuretic peptide levels measured preoperatively and postoperatively can be a prognostic indicator in the management of the pediatric patient after surgical intervention for congenital heart repair.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18179925     DOI: 10.1016/j.jtcvs.2007.08.012

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  9 in total

Review 1.  Plasma B-type natriuretic peptides in children with cardiovascular diseases.

Authors:  Bibhuti B Das
Journal:  Pediatr Cardiol       Date:  2010-10-07       Impact factor: 1.655

2.  Relationship between echocardiographic findings and laboratory serum biomarkers in patients with and without low cardiac output.

Authors:  Mohammad Reza Khalilian; Mohammad Reza Sabri; Abdolrasoul Nikyar; Shaghayegh Haghjooy Javanmard
Journal:  J Res Med Sci       Date:  2011-11       Impact factor: 1.852

3.  Changes in Plasma Atrial and Brain Natriuretic Peptide Levels in Children Undergoing Surgical Isolated Atrial Septal Defect Closure.

Authors:  Yuki Nakamura; Ikuo Hagino; Mitsuru Aoki; Kouji Higashi; Hiromichi Nakajima
Journal:  Pediatr Cardiol       Date:  2015-03-14       Impact factor: 1.655

4.  Aminoterminal Pro B-Type Natriuretic Peptide (NT-proBNP) Levels for Monitoring Interventions in Paediatric Cardiac Patients with Stenotic Lesions.

Authors:  Eva Welisch; Knut Kleesiek; Nikolaus Haas; Kambiz Norozi; Ralf Rauch; Guido Filler
Journal:  Int J Pediatr       Date:  2010-02-24

5.  Serum brain natriuretic peptide and risk of acute kidney injury after cardiac operations in children.

Authors:  Christoph P Hornik; Catherine D Krawczeski; Michael Zappitelli; Kwangik Hong; Heather Thiessen-Philbrook; Prasad Devarajan; Chirag R Parikh; Uptal D Patel
Journal:  Ann Thorac Surg       Date:  2014-04-13       Impact factor: 4.330

Review 6.  The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.

Authors:  Massimiliano Cantinotti; Yuk Law; Simona Vittorini; Maura Crocetti; Marotta Marco; Bruno Murzi; Aldo Clerico
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

7.  Risk Factors for Cardiac Adverse Events in Infants and Children with Complex Heart Disease Scheduled for Bi-ventricular Repair: Prognostic Value of Pre-operative B-Type Natriuretic Peptide and High-Sensitivity Troponin T.

Authors:  Yoshiki Mori; Yasumi Nakashima; Sachie Kaneko; Nao Inoue; Tomotaka Murakami
Journal:  Pediatr Cardiol       Date:  2020-08-17       Impact factor: 1.655

8.  The association between the pattern of change in N-terminal pro-B-type natriuretic peptide and short-term outcomes in children undergoing surgery for congenital heart disease.

Authors:  Haiqing Zheng; Yanqin Cui; Kuanrong Li; Jiexin Zhang; Jiangbo Qu; Hui Shi; LiJuan Li; Huimin Xia; Xinxin Chen; Huiying Liang
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-04-19

9.  Prognostic value of perioperative NT-proBNP after corrective surgery for pediatric congenital heart defects.

Authors:  Fangqin Lin; Lingling Zheng; Yanqin Cui; Weidan Chen; Ramit Kumar Gupta; Huixian Li; Xinxin Chen; Huimin Xia; Huiying Liang
Journal:  BMC Pediatr       Date:  2019-12-16       Impact factor: 2.125

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.